Thursday, June 7, 2012

Can Patient Discovery be practical for 42 CFR Part II Programs?

Does patient consent for a substance abuse provider to disclose their identity to another provider on a Health Information Exchange (HIE) also authorize subsequent disclosures to other providers on that HIE within 200 Miles?


I recently re-read the 42 Code of Federal Regulations (CFR) Part II for the purposes of building a Health Information Exchange (HIE) rules engine.  I found a section of this regulation that has particular relevance to a maintenance treatment program HIE seeking to conduct a "Patient Discovery".

Section 2.34 and the Central Registry exception for maintenance treatment programs
A substance abuse program that has received patient consent to disclose their identity to the central registry and thereby any/all programs associated with that central registry provided that the following conditions are met.
  1. Geography: The programs are within 200 miles of each other
    (programs in different states must also be within 125 miles of the central repository)
  2. Purpose: The purpose of the request and disclosure is to avoid patient enrollment in more than one maintenance treatment program (such as a narcotic dispensing program to treat morphine-like drugs)
  3. Event:
    • Patient Acceptance into treatment
    • Type/Dosage of Drug changed
    • Treatment of patient is interrupted, resumed, or terminated
  4. Patient consent: For HIE Repository to disclose identity    
  5. Patient Information limited to:
    • Patient Identifying Information
    • Medication 
    • "Relevant Dates"
Bottom Line:  Traditional "Patient Discovery" of substance abuse patients can be practical on HIEs with a 200 mile radius of providers.

References: 

No comments:

Post a Comment